With 2025 reaching its final weeks, we pause together to reflect on what we have built, strengthened, and delivered. This was not simply a year full of activity. It was a year in which we actively lived our mission. We advanced science, supported clinicians and researchers, expanded education beyond congress halls, and spoke clearly when evidence mattered. Above all, we strengthened a community united by a shared commitment to women’s health at midlife and beyond.
Women’s health is now firmly in the spotlight. With that visibility comes responsibility. As scientists and healthcare professionals, our role is to ensure that progress remains evidence-based, balanced, and ethical, and that we do not repeat the mistakes of the past. Much of what we achieved in 2025 reflects this responsibility.
Our Congress and a new chapter of leadership
The EMAS 2025 Congress marked a milestone for our community, with record-breaking participation and engagement. The scientific programme reflected the full breadth of midlife health, from menopause to cardiometabolic health, bone and muscle, mental health, sexual health, and healthy ageing.
The congress also marked an important moment of continuity and renewal. A new EMAS Board began its mandate during the meeting, allowing leadership transition and scientific continuity to move forward together, grounded in collaboration and shared values.
With this chapter complete, our attention is already turning to Gothenburg, where we will meet again to continue shaping the future of EMAS together.
By loading the video, you agree to YouTube's privacy policy.
Learn more
Investing in the next generation through JuMP
In 2025, the EMAS Junior Mentorship Programme entered a new edition with unprecedented interest. The record number of applications reflected a growing appetite among early-career clinicians and researchers for structured mentorship, international exchange, and research-driven learning.
Today, JuMP mentees are actively working with experienced EMAS mentors on research projects, academic development, and engagement with the wider EMAS community. JuMP remains a central expression of our belief that supporting early-career professionals is essential to the long-term strength of the field.
By loading the video, you agree to YouTube's privacy policy.
Learn more
Five Working Groups shaping our priorities
To support strategic growth through 2027, we launched five Working Groups in 2025. These groups bring together Board members, advisors, and invited experts, ensuring that our initiatives are shaped collaboratively and with long-term impact in mind.
- Education. Developing high-quality webinars, podcasts, and content for the upcoming EMAS learning platform, with a strong focus on clarity, accessibility, and clinical relevance.
- Research. Supporting good research practice, increasing the visibility of menopause-related research, and helping define future scientific priorities.
- Early Career. Actively involving early-career clinicians and researchers in shaping EMAS activities. Former JuMP mentees Kristina Saravinovska and Ipek Betul Ozcivit Erkan were invited to join this group, ensuring that the perspectives of the next generation directly inform our education, engagement, and future initiatives.
- Partnerships and Visibility. Strengthening collaborations with scientific societies and global networks, and identifying opportunities for EMAS representation at key congresses and events.
- Menopause in the Workplace. Expanding our leadership in workplace health, policy dialogue, and employer engagement.
Together, these Working Groups help translate expertise into action while keeping EMAS aligned with its mission and values.
Speaking clearly in a changing scientific landscape
In November, we responded to the U.S. FDA decision to remove long-standing Black Box warnings from menopausal hormone therapy. We welcomed this important regulatory correction, while clearly stating that it reflects long-established evidence rather than new data.
At the same time, we emphasised the need to avoid new extremes. Menopausal hormone therapy must remain individualised, evidence-based, and tailored to each woman’s needs and risk profile. Through an official statement and a live expert roundtable discussion, we reaffirmed our role as a trusted scientific voice at a time when balanced communication is essential.
By loading the video, you agree to YouTube's privacy policy.
Learn more
Education that continues throughout the year
Education remained a cornerstone of our shared work in 2025.
We launched a new monthly webinar series led by the Education Working Group, designed to provide continuity and depth across key areas of midlife health. We also released seven new podcast episodes, further expanding freely accessible EMAS educational content.
Menopause in the workplace. A year of sustained action
In 2025, we significantly expanded our work on menopause in the workplace, building on years of leadership in this area.
Anchored around World Menopause and Work Day, the campaign evolved into a multi-week global initiative rather than a single awareness moment. Key elements included:
- A free, open-to-all international webinar addressing menopause from occupational health, HR, psychological, social science, economic, and policy perspectives, with live captions, translation, and multi-platform streaming
- A daily podcast series released in the lead-up to World Menopause and Work Day, featuring clinicians, researchers, HR leaders, social scientists, and policymakers
- A community video initiative inviting EMAS board members, clinicians, researchers, advocates, and early-career professionals to share what a menopause-supportive workplace means to them
- Amplification of emerging international research, highlighting menopause at work as a systemic and global issue rather than an isolated concern
- The launch of the new edition of the EMAS CareOnline Publication “Health at Menopause and Beyond”, offering practical, evidence-based guidance aligned with real-world clinical and workplace needs
Through this campaign, menopause in the workplace was clearly framed as a health issue, a workforce and economic issue, and a matter of equity. Our aim was not to deliver a single message, but to create a platform for learning, exchange, and action.
By loading the video, you agree to YouTube's privacy policy.
Learn more
Advancing clinical practice
We continued to support clinical care through the publication of two new EMAS clinical guides in Maturitas.
Chronic kidney disease and menopausal health, addressing the complex interaction between ageing, menopause, cardiovascular risk, and kidney health.
Endometriosis and menopausal health, providing evidence-based guidance on symptom management, hormone therapy choices, and long-term care.
These publications reflect our collective commitment to nuanced, real-world clinical guidance grounded in science.
Looking ahead
Our focus is already moving toward what comes next. In the months ahead, we will announce new activities, including the launch of the EMAS Academy programme and registration, additional webinars and podcasts, and the first two-part webinar series organised by the Early Career Working Group.
More initiatives, collaborations, and a few surprises are in development, all driven by the same shared purpose that shaped 2025.
Season’s greetings from EMAS
With another impactful year behind us, we send warm season’s greetings to everyone who contributes to EMAS.
Thank you to every member, contributor, mentor, mentee, partner, and volunteer who helped make 2025 a year of impact. Together, we are advancing women’s health at midlife and beyond with science, care, and responsibility.
If you share this commitment and want to be part of a global community shaping the future of evidence-based menopause and midlife health, we warmly invite you to join EMAS and contribute to the work ahead.
We look forward to continuing this journey together.
By loading the video, you agree to YouTube's privacy policy.
Learn more
powered by Borlabs Cookie